Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia

444

Citations

30

References

1999

Year

Mitchell F. Brin, Mark Lew, Charles H. Adler, Cynthia Comella, Stewart A. Factor, Joseph Jankovic, C. O’Brien, JC Murray, J D Wallace, A. Willmer–Hulme,

Abstract

Botulinum toxin type B (BoNT/B) (NeuroBloc) is safe and efficacious for the management of patients with type A-resistant cervical dystonia with an estimated duration of treatment effect of 12 to 16 weeks.

References

	Year	Citations

Page 1